Mar 15, 2017 - Semaglutide significantly reduced the composite outcome of CV death, nonfatal myocardial infarction, and nonfatal stroke (number needed to treat [NNT] = 43 over 2.1 years). It was generally well tolerated, and it reduced body weight by approximately 6.4 to 9.5 lb (2.9 to 4.3 kg).
American Family Physician : POEMs
Nov 15, 2009 - Recommendations from the American Diabetes Association (ADA), American College of Cardiology Foundation (ACC), and American Heart Association (AHA) for glycemic control and prevention of cardiovascular events in patients with diabetes.
American Family Physician : Practice Guidelines